TY  - JOUR

T1  - Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

JO  - JAMA Neurology

UR  - https://eprints.whiterose.ac.uk/id/eprint/200864

PY  - 2023/05/15

AU  - Kalincik T

AU  - Sharmin S

AU  - Roos I

AU  - Freedman MS

AU  - Atkins H

AU  - Burman J

AU  - Massey J

AU  - Sutton I

AU  - Withers B

AU  - Macdonell R

AU  - Grigg A et al

ED  - 

DO  - DOI: 10.1001/jamaneurol.2023.1184

PB  - American Medical Association (AMA)

VL  - 80

IS  - 7

SP  - 702

EP  - 713

Y2  - 2024/12/22

ER  -